Beyond Ozempic: the GLP-1 landscape in 2026
There is a lot going on in the GLP-1 space, a market that landed $79 billion last year, and could shift significantly in the coming years. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.